Leonardus H.t. van der Ploeg, Chief Scientific Officer at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 38,000 shares at $30.09 ($1.1M) on 2018-11-02, disclosed to the SEC on 2018-11-06.
Open-market sale of $1.1M RYTM by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RYTM | SELL | 2019-01-18 | $6K | — | Filing → |
| RYTM | SELL | 2018-09-27 | $1.9M | — | Filing → |